Latest News

Testing Parkinson's disease immune-based drugs: New models

Using powerful, newly developed cell culture and mouse models of sporadic Parkinson?s disease (PD), researchers have demonstrated that immunotherapy with specifically targeted antibodies may block the development and spread of PD pathology in the brain. By intercepting the distorted and misfolded alpha-synuclein (?-syn) proteins that enter and propagate in neurons, creating aggregates, the researchers prevented the development of pathology and also reversed some of the effects of already-existing disease.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Predicting who will develop multiple sclerosis

  • Older and younger adults surf different brain waves

  • Persistent ADHD associated with overly critical parents

  • Using medical marijuana to stop seizures in kids

  • Millennials say one thing but do another when choosing chocolate

  • New device to get people with paralysis back on their feet

  • Research finds no easy answers to use of drug screening for pain patients

  • Brain scars in multiple sclerosis patients reveal possible cause of taste problems

  • Wbp2 is a novel deafness gene

  • New wireless sleeve to help people recover arm use after stroke

  •